These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 27048810)
1. Cancer and necroptosis: friend or foe? Philipp S; Sosna J; Adam D Cell Mol Life Sci; 2016 Jun; 73(11-12):2183-93. PubMed ID: 27048810 [TBL] [Abstract][Full Text] [Related]
2. Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis. Philipp S; Sosna J; Plenge J; Kalthoff H; Adam D Cell Commun Signal; 2015 Apr; 13():25. PubMed ID: 25925126 [TBL] [Abstract][Full Text] [Related]
3. Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells. Sosna J; Philipp S; Fuchslocher Chico J; Saggau C; Fritsch J; Föll A; Plenge J; Arenz C; Pinkert T; Kalthoff H; Trauzold A; Schmitz I; Schütze S; Adam D Mol Cell Biol; 2016 Oct; 36(20):2626-44. PubMed ID: 27528614 [TBL] [Abstract][Full Text] [Related]
4. TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis. Karl I; Jossberger-Werner M; Schmidt N; Horn S; Goebeler M; Leverkus M; Wajant H; Giner T Cell Death Dis; 2014 Oct; 5(10):e1444. PubMed ID: 25299769 [TBL] [Abstract][Full Text] [Related]
5. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Meng MB; Wang HH; Cui YL; Wu ZQ; Shi YY; Zaorsky NG; Deng L; Yuan ZY; Lu Y; Wang P Oncotarget; 2016 Aug; 7(35):57391-57413. PubMed ID: 27429198 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. Shirjang S; Mansoori B; Asghari S; Duijf PHG; Mohammadi A; Gjerstorff M; Baradaran B Free Radic Biol Med; 2019 Aug; 139():1-15. PubMed ID: 31102709 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of necroptosis in normal and cancer cells. Fulda S Cancer Biol Ther; 2013 Nov; 14(11):999-1004. PubMed ID: 24025353 [TBL] [Abstract][Full Text] [Related]
8. RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection. Liao Y; Wang HX; Mao X; Fang H; Wang H; Li Y; Sun Y; Meng C; Tan L; Song C; Qiu X; Ding C Oncotarget; 2017 Jun; 8(26):43201-43217. PubMed ID: 28591723 [TBL] [Abstract][Full Text] [Related]
9. Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis. Anany MA; Kreckel J; Füllsack S; Rosenthal A; Otto C; Siegmund D; Wajant H Cell Death Dis; 2018 Oct; 9(11):1084. PubMed ID: 30349023 [TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223 [TBL] [Abstract][Full Text] [Related]
11. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor. Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689 [TBL] [Abstract][Full Text] [Related]
12. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells. Pal S; Shankar BS; Sainis KB Cytokine; 2013 Oct; 64(1):196-207. PubMed ID: 23972545 [TBL] [Abstract][Full Text] [Related]
13. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines. Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396 [TBL] [Abstract][Full Text] [Related]
14. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202 [TBL] [Abstract][Full Text] [Related]
16. The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics. Seo J; Kim MW; Bae KH; Lee SC; Song J; Lee EW Biochem Pharmacol; 2019 Apr; 162():21-40. PubMed ID: 30452908 [TBL] [Abstract][Full Text] [Related]
17. Autophagy as a mechanism of Apo2L/TRAIL resistance. Sharma A; Almasan A Cancer Biol Ther; 2018; 19(9):755-762. PubMed ID: 30067424 [TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776 [TBL] [Abstract][Full Text] [Related]
19. Necroptosis mediates TNF-induced toxicity of hippocampal neurons. Liu S; Wang X; Li Y; Xu L; Yu X; Ge L; Li J; Zhu Y; He S Biomed Res Int; 2014; 2014():290182. PubMed ID: 25093162 [TBL] [Abstract][Full Text] [Related]